ID

16012

Beschreibung

Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193011

Link

https://clinicaltrials.gov/show/NCT00193011

Stichworte

  1. 02.05.16 02.05.16 -
  2. 26.06.16 26.06.16 -
Hochgeladen am

26. Juni 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00193011

Eligibility Breast Cancer NCT00193011

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
to be included in this study, you must meet the following criteria:
Beschreibung

Inclusion criteria

Datentyp

boolean

female patients with adenocarcinoma of the breast confirmed by biopsy
Beschreibung

female patients with adenocarcinoma of the breast

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0019638
UMLS CUI [1,3]
C0678222
age 65 or older
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
under age 65 must have significant medical illness, or general frailty
Beschreibung

significant medical illness

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0205082
UMLS CUI [1,2]
C0221423
UMLS CUI [2]
C0424594
adequate bone marrow, liver or kidney function
Beschreibung

bone marrow, liver or kidney function

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0232741
UMLS CUI [1,3]
C0232804
normal heart function
Beschreibung

cardiac function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232164
less than 84 days from mastectomy/lumpectomy or axillary dissection
Beschreibung

time since surgery

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1272706
UMLS CUI [1,2]
C3714726
signed consent obtained prior to initiation of any study procedures
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Beschreibung

Exclusion Criteria

Datentyp

boolean

received neo-adjuvant therapy
Beschreibung

Neoadjuvant Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0600558
primary tumor is locally advanced at diagnosis
Beschreibung

locally advanced tumor

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0205179
UMLS CUI [1,2]
C0678222
received prior chemotherapy within five years
Beschreibung

prior chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C1514457
received previous radiation therapy within 5 years
Beschreibung

previous radiation therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
peripheral neuropathy
Beschreibung

Peripheral Neuropathy

Datentyp

boolean

Alias
UMLS CUI [1]
C0031117
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Beschreibung

ID.15

Datentyp

boolean

Ähnliche Modelle

Eligibility Breast Cancer NCT00193011

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Inclusion criteria
Item
to be included in this study, you must meet the following criteria:
boolean
female patients with adenocarcinoma of the breast
Item
female patients with adenocarcinoma of the breast confirmed by biopsy
boolean
C0079399 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
age
Item
age 65 or older
boolean
C0001779 (UMLS CUI [1])
significant medical illness
Item
under age 65 must have significant medical illness, or general frailty
boolean
C0205082 (UMLS CUI [1,1])
C0221423 (UMLS CUI [1,2])
C0424594 (UMLS CUI [2])
bone marrow, liver or kidney function
Item
adequate bone marrow, liver or kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
cardiac function
Item
normal heart function
boolean
C0232164 (UMLS CUI [1])
time since surgery
Item
less than 84 days from mastectomy/lumpectomy or axillary dissection
boolean
C1272706 (UMLS CUI [1,1])
C3714726 (UMLS CUI [1,2])
informed consent
Item
signed consent obtained prior to initiation of any study procedures
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Exclusion Criteria
Item
you cannot participate in this study if any of the following apply to you:
boolean
Neoadjuvant Therapy
Item
received neo-adjuvant therapy
boolean
C0600558 (UMLS CUI [1])
locally advanced tumor
Item
primary tumor is locally advanced at diagnosis
boolean
C0205179 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
prior chemotherapy
Item
received prior chemotherapy within five years
boolean
C1514457 (UMLS CUI [1])
previous radiation therapy
Item
received previous radiation therapy within 5 years
boolean
C1522449 (UMLS CUI [1])
Peripheral Neuropathy
Item
peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
ID.15
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video